Jonathan Bernhard

Jonathan Bernhard is an experienced professional in corporate development and biomedical engineering, currently serving as Director of Corporate Development at AnaptysBio since November 2024. Prior roles include Director and Associate Director of Corporate Development at Fulcrum Therapeutics, and Senior Manager and Manager of Strategic Insights and Analytics at Foundation Medicine. Jonathan's earlier career involved consultancy at ClearView Healthcare Partners and postdoctoral research at Columbia University, where Jonathan also earned a PhD in Biomedical/Medical Engineering. Jonathan co-founded EpiBone and held a Whitaker International Fellowship at the Ludwig Boltzmann Institute for Experimental and Clinical Traumatology. Educationally, Jonathan holds a Master of Science from Purdue University and a Bachelor of Science in Biomedical Engineering.